GO:1902895 positive regulation of miRNA transcription: Regulatory Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902895 describes any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription.
• miRNA transcription is primarily driven by RNA polymerase II, producing primary miRNA (pri-miRNA) transcripts that are later processed into mature miRNAs.
• Positive regulation of miRNA transcription is essential for controlling gene expression programs in development, immunity, and disease.
• Dysregulation of miRNA transcription is implicated in cancer, autoimmune diseases, and neurological disorders such as schizophrenia.
• Key transcription factors and cofactors, including p53, Sp1, Egr1, and CREB, directly or indirectly promote miRNA gene transcription.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal dissection of miRNA transcriptional regulatory networks.
Description
MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally regulate gene expression by binding to target mRNAs. The production of miRNAs begins with transcription of miRNA genes, predominantly by RNA polymerase II, generating primary miRNA transcripts (pri-miRNAs). The Gene Ontology term GO:1902895, positive regulation of miRNA transcription, captures any process that activates or increases the frequency, rate or extent of miRNA gene transcription. This term is critical for understanding how cells adjust miRNA repertoires in response to developmental cues, stress, and disease signals. Research over the past two decades has revealed that miRNA transcription is not constitutive but is tightly controlled by sequence-specific transcription factors, epigenetic modifiers, and signaling pathways. For example, the tumor suppressor p53 directly activates transcription of the miR-34 family, which mediates cell cycle arrest and apoptosis. Similarly, transcription factors such as Sp1, Egr1, and CREB regulate monoamine oxidase B gene expression and are themselves modulated by miRNAs, highlighting bidirectional regulatory loops. Dysregulation of positive regulation of miRNA transcription contributes to a wide range of pathologies, including cancer, autoimmune diseases, and neuropsychiatric disorders. Understanding the molecular players and mechanisms underlying this GO term is therefore essential for both basic biology and therapeutic development. This article provides a comprehensive overview of GO:1902895, covering its definition, biological significance, core mechanisms, key genes, disease links, and state-of-the-art research methods including CRISPR-based models.
positive regulation of miRNA transcription At A Glance
| GO ID | GO:1902895 |
|---|---|
| GO term | positive regulation of miRNA transcription |
| Ontology | biological_process |
| Synonym | activation of pri-miRNA transcription from RNA polymerase II promoter; positive regulation of microRNA gene transcription; positive regulation of primary miRNA gene transcription; positive regulation of pri-miRNA gene transcription; positive regulation of pri-miRNA transcription by RNA polymerase II; positive regulation of pri-miRNA transcription from RNA polymerase II promoter; up regulation of pri-miRNA transcription from RNA polymerase II promoter; up-regulation of pri-miRNA transcription from RNA polymerase II promoter; upregulation of pri-miRNA transcription from RNA polymerase II promoter |
| Major function | Increases the transcription of miRNA genes, leading to elevated levels of primary miRNA transcripts and ultimately mature miRNAs. |
| Related process | Regulation of gene expression; miRNA processing; RNA polymerase II transcription. |
| Cellular location | Nucleus, specifically at miRNA gene promoters. |
| Key regulators | Transcription factors such as p53, Sp1, Egr1, CREB; coactivators and chromatin modifiers. |
What Is GO:1902895?
GO:1902895 (positive regulation of miRNA transcription) is a biological process term defined as any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription. In practice, this encompasses the action of transcription factors, coactivators, chromatin remodelers, and signaling cascades that enhance the transcription of miRNA genes by RNA polymerase II, leading to increased production of primary miRNA transcripts (pri-miRNAs).
Why Is positive regulation of miRNA transcription Important in Cell Biology?
Positive regulation of miRNA transcription is a central node in gene regulatory networks because miRNAs fine-tune the expression of hundreds of target mRNAs. By controlling when and where miRNA genes are transcribed, cells can rapidly reshape their transcriptome in response to developmental, metabolic, and immune signals. Dysregulation of this process is causally linked to cancer, autoimmune disorders, and neurological diseases, making it a prime target for therapeutic intervention and biomarker discovery.
• Controls the abundance of mature miRNAs, which collectively regulate more than 60% of human protein-coding genes.
• Essential for normal development, differentiation, and tissue homeostasis.
• Dysregulation contributes to tumorigenesis, including altered expression of oncogenic and tumor-suppressive miRNAs.
• Implicated in autoimmune diseases such as systemic lupus erythematosus through BAFF overexpression and miRNA dysregulation.
• Associated with neuropsychiatric disorders like schizophrenia, where miRNA-mRNA regulatory networks are disrupted.
• Provides a mechanism for feedback and feedforward loops in gene regulatory circuits.
• Key for cellular responses to hypoxia, angiogenesis, and metabolic stress.
• Enables experimental dissection of causal gene function using CRISPR screens and targeted editing.
What Happens During positive regulation of miRNA transcription?
Transcription factor recruitment to miRNA gene promoters
In simple terms: Special proteins called transcription factors bind to the DNA near miRNA genes and switch them on.
Positive regulation of miRNA transcription begins with the binding of sequence-specific transcription factors to promoter or enhancer regions of miRNA genes. For example, the tumor suppressor p53 binds to regulatory elements of the miR-34a gene and activates its transcription in response to DNA damage. Similarly, transcription factors Sp1, Egr1, and CREB regulate the monoamine oxidase B gene and are modulated by miRNAs such as miR-300 and miR-1224, illustrating complex feedback. These DNA-protein interactions recruit coactivators and chromatin-modifying enzymes that facilitate RNA polymerase II engagement.
Chromatin remodeling and epigenetic activation
In simple terms: The DNA packaging must be loosened so that the transcription machinery can access miRNA genes.
Efficient transcription of miRNA genes requires a permissive chromatin state. Positive regulators often recruit histone acetyltransferases and ATP-dependent chromatin remodelers that acetylate histones and mobilize nucleosomes, thereby increasing accessibility of miRNA promoters. Conversely, removal of repressive marks such as histone deacetylation or DNA methylation is associated with enhanced miRNA transcription. Epigenetic drugs that inhibit DNA methyltransferases or histone deacetylases can therefore indirectly stimulate miRNA gene expression.
Assembly of the RNA polymerase II preinitiation complex
In simple terms: A large molecular machine called RNA polymerase II assembles on the miRNA gene to start copying DNA into RNA.
Once transcription factors and coactivators have created a favorable chromatin environment, general transcription factors (TFIIA, TFIIB, TFIID, TFIIE, TFIIF, TFIIH) and RNA polymerase II assemble at the core promoter of miRNA genes to form the preinitiation complex. This step is rate-limiting and is often the target of regulatory inputs. For instance, p53 can directly interact with components of the preinitiation complex to enhance transcription of its target miRNA genes. The phosphorylation status of the RNA polymerase II C-terminal domain also influences elongation efficiency.
Transcriptional elongation and production of primary miRNA transcripts
In simple terms: The polymerase moves along the gene, producing a long RNA copy called pri-miRNA.
Following initiation, RNA polymerase II transitions to productive elongation, generating primary miRNA transcripts (pri-miRNAs) that can be several kilobases long. Positive regulation of miRNA transcription increases the frequency and processivity of elongation, leading to higher steady-state levels of pri-miRNAs. These pri-miRNAs are subsequently processed by the Microprocessor complex (Drosha/DGCR8) in the nucleus and Dicer in the cytoplasm to yield mature miRNAs. Thus, enhanced transcription directly translates into elevated mature miRNA levels, although additional post-transcriptional regulation exists.
Feedback and signal integration
In simple terms: The process is fine-tuned by signals from inside and outside the cell, including other miRNAs.
Positive regulation of miRNA transcription is embedded in complex regulatory networks. miRNAs can act as endogenous decoys of transcription factors, sequestering them from promoters and thereby modulating their own transcription. For example, miR-300 and miR-1224 influence the activity of Sp1, Egr1, and CREB, which in turn regulate miRNA gene expression. Additionally, hypoxia-inducible factors (HIFs) activate transcription of angiogenic miRNAs such as miR-210 under low oxygen conditions. These feedback loops ensure that miRNA levels are appropriately matched to cellular state.
Key Genes Involved in GO:1902895 positive regulation of miRNA transcription
The following genes and proteins are central to the positive regulation of miRNA transcription, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TP53 | Transcription factor that activates miR-34 family and other tumor-suppressive miRNAs | Most frequently mutated gene in cancer; p53-miRNA axis is a major research focus |
| SP1 | Sequence-specific transcription factor that binds GC-rich promoters of many miRNA genes | Regulates monoamine oxidase B and is modulated by miR-300/miR-1224 |
| EGR1 | Immediate-early transcription factor that activates miRNA genes in response to growth signals | Involved in neuronal plasticity and cancer; regulated by miR-300/miR-1224 |
| CREB1 | cAMP-responsive transcription factor that promotes transcription of miRNA genes | Key mediator of metabolic and neuronal signaling; modulated by miR-1224 |
| HIF1A | Hypoxia-inducible factor that activates angiogenic miRNAs such as miR-210 | Central to hypoxia response and tumor angiogenesis |
| BAFF (TNFSF13B) | Cytokine that influences B-cell survival and autoimmunity; its overexpression is linked to miRNA dysregulation | Autoimmune disease risk; potential target for miRNA-based therapies |
| DROSHA | RNase III enzyme that processes pri-miRNAs into pre-miRNAs | Essential for miRNA biogenesis; its expression is coordinated with transcription |
| DGCR8 | Double-stranded RNA-binding protein that partners with DROSHA | Required for pri-miRNA processing; links transcription to processing |
| DICER1 | Cytoplasmic RNase III enzyme that produces mature miRNA duplexes | Rate-limiting for mature miRNA production; often dysregulated in cancer |
| AGO2 | Argonaute protein that incorporates mature miRNAs into RISC | Effector of miRNA silencing; its levels can feedback on transcription |
| POLR2A | Largest subunit of RNA polymerase II | Catalyzes transcription of miRNA genes; target of regulatory phosphorylation |
| CDK9 | Cyclin-dependent kinase that phosphorylates RNA polymerase II CTD to promote elongation | Positive regulator of miRNA transcription elongation |
| BRD4 | Bromodomain protein that recruits P-TEFb to promoters | Enhances transcriptional elongation of miRNA genes; target of BET inhibitors |
| KAT2A (GCN5) | Histone acetyltransferase that acetylates histones at miRNA promoters | Epigenetic activator of miRNA transcription |
| HDAC1 | Histone deacetylase that removes acetyl groups, generally repressing transcription | Its inhibition can indirectly increase miRNA transcription |
| DNMT1 | DNA methyltransferase that methylates CpG islands, often silencing miRNA genes | Inhibition leads to re-expression of tumor-suppressive miRNAs |
| XPO5 | Exportin-5 that transports pre-miRNAs from nucleus to cytoplasm | Links nuclear transcription/processing to cytoplasmic maturation |
| TNRC6A | GW182 family protein involved in miRNA-mediated silencing | Component of RISC; can influence feedback on miRNA transcription |
How Is positive regulation of miRNA transcription Regulated?
Positive regulation of miRNA transcription is controlled at multiple levels. Upstream signaling pathways such as DNA damage response (p53), cAMP/PKA (CREB), growth factor signaling (Egr1), and hypoxia (HIF1A) converge on transcription factors that bind miRNA gene promoters. Epigenetic modifiers, including histone acetyltransferases (e.g., KAT2A) and DNA methyltransferases (e.g., DNMT1), alter chromatin accessibility and thus the rate of transcription. Additionally, miRNAs themselves can act as decoys for transcription factors, creating feedback loops that fine-tune their own expression. For example, miR-300 and miR-1224 modulate Sp1, Egr1, and CREB activity, which in turn regulate miRNA gene transcription. This multilayered regulation ensures precise control of miRNA levels in response to cellular cues.
positive regulation of miRNA transcription and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TP53 | Cancer (multiple types); loss of p53 reduces miR-34 transcription | TP53 knockout and point-mutant cell lines; miR-34 reporter assays |
| BAFF (TNFSF13B) | Autoimmune diseases (SLE, Sjögren's syndrome); BAFF overexpression alters miRNA profiles | BAFF-overexpressing transgenic mice or cell lines; miRNA profiling |
| HIF1A | Hypoxia-related diseases, cancer angiogenesis; activates miR-210 transcription | HIF1A knockout or knockdown under hypoxia; miR-210 promoter assays |
| SP1/EGR1/CREB1 | Neurological and metabolic disorders; regulate MAO-B and miRNA genes | Knockout/knockdown of Sp1, Egr1, or CREB1; miRNA target validation |
| DICER1 | Cancer, developmental disorders; global miRNA processing | DICER1 conditional knockout; small RNA sequencing |
Cancer
Dysregulation of positive regulation of miRNA transcription is a hallmark of many cancers. The p53 tumor suppressor directly activates transcription of the miR-34 family, which induces cell cycle arrest, apoptosis, and senescence. Loss of p53 function, common in human tumors, leads to reduced miR-34 levels and impaired tumor suppression. Conversely, oncogenic transcription factors can aberrantly activate miRNAs that promote proliferation and survival. For example, hypoxia-inducible factor HIF1A stimulates transcription of miR-210, which supports angiogenesis and metabolic adaptation in hypoxic tumor regions. Targeting the transcriptional machinery that controls miRNA genes is therefore an attractive therapeutic strategy.
Autoimmune diseases
The cytokine BAFF (TNFSF13B) is overexpressed in several autoimmune diseases, including systemic lupus erythematosus and Sjögren's syndrome. BAFF overexpression is associated with altered miRNA expression profiles, suggesting that positive regulation of miRNA transcription contributes to autoimmune pathogenesis. miRNAs regulated by BAFF signaling can modulate B-cell survival and autoantibody production, making this pathway a potential target for therapeutic intervention.
Neuropsychiatric disorders
Schizophrenia is a complex neuropsychiatric disorder with heterogeneous positive and negative symptoms. Transcriptome sequencing studies have identified miRNA-mRNA regulatory networks associated with symptom severity, implicating dysregulated miRNA transcription in disease pathophysiology. Specific miRNAs and their target mRNAs show altered expression in schizophrenia patients, and these changes may reflect aberrant positive regulation of miRNA transcription. Understanding these networks could lead to novel biomarkers and treatments.
Metabolic and angiogenic disorders
Hypoxia-induced miRNA transcription, mediated by HIF1A, plays a critical role in angiogenesis and metabolic adaptation. miR-210, a well-known hypoxia-inducible miRNA, is transcriptionally activated under low oxygen conditions and affects mitochondrial metabolism and angiogenesis. Dysregulation of this process contributes to ischemic diseases, diabetic complications, and tumor progression. Modulating positive regulation of miRNA transcription may offer therapeutic benefits in these conditions.
From positive regulation of miRNA transcription-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does a candidate transcription factor directly activate a miRNA gene? | Knockout of the transcription factor followed by pri-miRNA qPCR and ChIP |
| Does a specific point mutation in a transcription factor alter miRNA transcription? | Point-mutation knock-in cell lines (e.g., p53 mutants) |
| Does a miRNA promoter variant affect transcription? | Knock-in of promoter reporter or tagged allele; luciferase assays |
| What is the effect of overexpressing a miRNA gene? | Overexpression cell models using lentiviral or CRISPRa systems |
| Which genes regulate miRNA transcription genome-wide? | CRISPR library screening with miRNA reporters |
| How does chromatin state affect miRNA transcription? | Knockout of epigenetic modifiers (e.g., DNMT1, HDAC1) followed by miRNA profiling |
How to Study the positive regulation of miRNA transcription Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Steady-state levels of pri-miRNAs and mature miRNAs | Global profiling of miRNA transcription changes |
| Small RNA-seq | Mature miRNA expression | Quantifying specific miRNA levels after perturbation |
| ChIP-seq | Genome-wide binding of transcription factors and histone marks | Identifying direct regulators of miRNA genes |
| Luciferase reporter assay | Transcriptional activity of miRNA promoter fragments | Testing direct activation by transcription factors |
| CRISPR knockout screen | Genes required for miRNA transcription | Discovery of novel regulators |
| CRISPR activation (CRISPRa) screen | Genes whose overexpression enhances miRNA transcription | Identifying positive regulators |
| Proteomics (AP-MS, BioID) | Protein interactions at miRNA promoters | Mapping regulatory complexes |
| Nascent RNA capture (GRO-seq, PRO-seq) | Transcription rate and polymerase occupancy | Measuring direct effects on miRNA transcription |
Transcriptomic profiling of pri-miRNAs and mature miRNAs
RNA sequencing (RNA-seq) can quantify primary miRNA transcripts and mature miRNAs, providing a snapshot of transcriptional activity. Small RNA-seq specifically captures mature miRNAs, while total RNA-seq or nascent RNA capture (e.g., GRO-seq) can measure pri-miRNA levels and transcription rates. These methods are essential for identifying miRNAs whose transcription is positively regulated under specific conditions.
Chromatin immunoprecipitation and promoter assays
Chromatin immunoprecipitation (ChIP) followed by qPCR or sequencing allows researchers to determine whether transcription factors and coactivators occupy miRNA gene promoters. Luciferase reporter assays with miRNA promoter fragments can test direct transcriptional activation. These approaches establish causal links between transcription factors and miRNA gene transcription.
CRISPR-based genetic screens
Genome-wide CRISPR knockout or activation screens using miRNA-responsive reporters can identify positive regulators of miRNA transcription. Such screens have uncovered novel components of the miRNA biogenesis and regulatory machinery. Coupling screens with single-cell RNA-seq provides high-resolution mapping of regulatory networks.
Proteomics and interactomics
Mass spectrometry-based proteomics can identify proteins associated with miRNA gene promoters or the transcription machinery. Proximity labeling (e.g., BioID, APEX) enables discovery of transient interactions between transcription factors and chromatin at miRNA loci. These methods complement genetic approaches by revealing physical components of the regulatory complexes.
How CRISPR Can Be Used to Study GO:1902895 positive regulation of miRNA transcription
Knockout
CRISPR knockout (KO) of candidate transcription factors or coactivators is a powerful approach to test their necessity for positive regulation of miRNA transcription. For example, TP53 KO cells show reduced miR-34 levels upon DNA damage, confirming p53 as a direct activator. Genome-wide KO screens with miRNA reporters can identify previously unknown regulators. KO models are essential for establishing causal roles in miRNA transcriptional control.
Point Mutation
Point mutations in transcription factor DNA-binding domains or in miRNA promoter elements can dissect specific regulatory interactions. For instance, knock-in of cancer-associated p53 missense mutations abolishes its ability to activate miR-34 transcription, linking genotype to miRNA dysregulation. Point-mutation models are invaluable for understanding how disease-associated variants affect miRNA transcription.
Knock-in
Knock-in of reporter genes (e.g., luciferase, GFP) under the control of endogenous miRNA promoters allows real-time monitoring of transcriptional activity. Tagged knock-in of transcription factors (e.g., FLAG, HA) enables ChIP and proteomic studies at endogenous loci. These models provide physiological context for studying positive regulation of miRNA transcription.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of transcription factors can drive ectopic activation of miRNA genes. Overexpression of BAFF, for example, alters miRNA profiles in B cells, mimicking autoimmune conditions. Overexpression models are useful for gain-of-function studies and for validating sufficiency of a regulator in activating miRNA transcription.
How EDITGENE Supports positive regulation of miRNA transcription Research
Researchers studying positive regulation of miRNA transcription-related genes often need to determine whether a candidate gene is causally involved in activating miRNA gene expression. EDITGENE provides comprehensive CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of transcriptional regulators and their target miRNA genes.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of miRNA transcription research.
Frequently Asked Questions About positive regulation of miRNA transcription
What is GO:1902895 positive regulation of miRNA transcription?
GO:1902895 is a Gene Ontology biological process term defined as any process that activates or increases the frequency, rate or extent of microRNA (miRNA) gene transcription.
What genes are involved in positive regulation of miRNA transcription?
Key genes include transcription factors such as TP53, SP1, EGR1, CREB1, and HIF1A, as well as epigenetic modifiers like DNMT1 and HDAC1.
How is miRNA transcription regulated?
miRNA transcription is regulated by sequence-specific transcription factors, chromatin remodeling, and signaling pathways that converge on miRNA gene promoters.
What diseases are associated with dysregulated miRNA transcription?
Dysregulated miRNA transcription is linked to cancer, autoimmune diseases, schizophrenia, and hypoxia-related disorders.
What is the role of p53 in miRNA transcription?
p53 directly activates transcription of the miR-34 family and other tumor-suppressive miRNAs in response to DNA damage.
How can CRISPR be used to study positive regulation of miRNA transcription?
CRISPR knockout, point mutation, knock-in, and overexpression models allow researchers to test the causal role of specific genes in activating miRNA transcription.
What methods are used to measure miRNA transcription?
RNA-seq, small RNA-seq, ChIP-seq, luciferase reporter assays, and nascent RNA capture are commonly used to measure miRNA transcription.
What is the difference between pri-miRNA and mature miRNA?
Pri-miRNA is the primary transcript produced by RNA polymerase II, while mature miRNA is the processed, functional small RNA generated after nuclear and cytoplasmic cleavage steps.
Can miRNAs regulate their own transcription?
Yes, miRNAs can act as decoys for transcription factors, creating feedback loops that modulate their own transcription.
How does hypoxia affect miRNA transcription?
Hypoxia stabilizes HIF1A, which activates transcription of miRNAs such as miR-210 that promote angiogenesis and metabolic adaptation.
Conclusion
GO:1902895 (positive regulation of miRNA transcription) is a fundamental biological process that controls the production of miRNAs, which in turn regulate a vast array of target genes. Its dysregulation is implicated in cancer, autoimmunity, and neuropsychiatric disorders, making it a critical area of research. Advances in CRISPR-based models and high-throughput sequencing are rapidly expanding our understanding of the transcriptional networks that govern miRNA gene expression. EDITGENE provides the tools and services needed to dissect these mechanisms with precision, empowering researchers to translate discoveries into therapeutic strategies.
References
- 1. Zhang Y et al.. 2013. Circular intronic long noncoding RNAs.. Mol Cell 51(6):792-806 PMID: 24035497
- 2. Liu J et al.. 2017. MicroRNA Control of p53.. J Cell Biochem 118(1):7-14 PMID: 27216701
- 3. Steri M et al.. 2017. Overexpression of the Cytokine BAFF and Autoimmunity Risk.. N Engl J Med 376(17):1615-1626 PMID: 28445677
- 4. Jin M et al.. 2024. Exploration of Positive and Negative Schizophrenia Symptom Heterogeneity and Establishment of Symptom-Related miRNA-mRNA Regulatory Network: Based on Transcriptome Sequencing Data.. Mol Neurobiol 61(8):5992-6012 PMID: 38267752
- 5. Afonso-Grunz F et al.. 2015. Principles of miRNA-mRNA interactions: beyond sequence complementarity.. Cell Mol Life Sci 72(16):3127-41 PMID: 26037721
- 6. Hua Z et al.. 2006. MiRNA-directed regulation of VEGF and other angiogenic factors under hypoxia.. PLoS One 1(1):e116 PMID: 17205120
- 7. Cui C et al.. 2014. Transcriptional regulation of gene expression by microRNAs as endogenous decoys of transcription factors.. Cell Physiol Biochem 33(6):1698-714 PMID: 24923223
- 8. Arige V et al.. 2019. Regulation of Monoamine Oxidase B Gene Expression: Key Roles for Transcription Factors Sp1, Egr1 and CREB, and microRNAs miR-300 and miR-1224.. J Mol Biol 431(6):1127-1147 PMID: 30738894
